Hodgkin's lymphoma in the elderly: The results of 10 years of follow-up

References

• Medeiros L J, Greiner T C. Hodgkin's disease. Cancer 1995; 75: 357–369
   PubMed Web of Science ®Google Scholar
• Diehl V, Thomas R K, Re D. Part II: Hodgkin's lymphoma – diagnosis and treatment. Lancet Oncol 2004; 1: 19–26
   Web of Science ®Google Scholar
• Haybittle L J, Haghoe F G, Easterling M J, Jeliffe A M, Bennett M H, Vaughan Hudson G. Review of British National Lymphoma Investigation studies of Hodgkin's disease and development of prognostic index. Lancet 1985; 1: 967–972
   PubMed Web of Science ®Google Scholar
• Tubiana M, Henry-Amar M, van der Werf-Messing B, Henry J, Abbatucci J, Burgers M. A multivariate analysis of prognostic factors in early stage Hodgkin's disease. Int J Radiat Oncol Biol Phys 1985; 11: 23–30
   PubMed Web of Science ®Google Scholar
• Rodgers R W, Fuller L M, Hagemeister F B, Johnston D A, Sullivan J A, North L B, et al. Reassesment of prognostic factors in stage IIIA and IIIB Hodgkin's disease treated with MOPP and radiotherapy. Cancer 1981; 47: 2196–2203
   PubMed Web of Science ®Google Scholar
• Gobbi B, Cavalli C, Frederico M, Lombardo M, Bertoloni D, Grignani G E, et al. Increasing interdependency of prognosis- and therapy related factors in Hodgkin's disease. Acta Haematol 1989; 81: 34–40
   PubMed Web of Science ®Google Scholar
• Lokich J J, Pinkus G S, Moloney W C. Hodgkin's disease in the elderly. Oncology 1974; 29: 484–500
   PubMed Web of Science ®Google Scholar
• Austin-Seymour M M, Hoppe R T, Cox R S, Rosenberg S A, Kaplan H S. Hodgkin's disease in patients over 60 years old. Ann Intern Med 1984; 100: 13–18
   PubMed Web of Science ®Google Scholar
• Tirelli U. Management of malignant lymphoma in the elderly: an EORTC retrospective evaluation. Acta Oncol 1989; 28: 199–201
   PubMed Web of Science ®Google Scholar
• Eghbali H, Hoerni-Simon G, de Mascarel I, Durand M, Chauvergne J, Hoerni B. Hodgkin's disease in the elderly: a series of 30 patients aged older than 70 years. Cancer 1984; 53: 2191–2193
   PubMed Web of Science ®Google Scholar
• Walker A, Schoenfeld E R, Lowman J T, Mettlin J T, MacMillan J, Grufferman S. Survival of the older patient compared with the younger patient with Hodgkin's disease. Influence of histologic type, staging and treatment. Cancer 1990; 65: 1635–1640
   PubMed Web of Science ®Google Scholar
• Guinee V F, Giacco G G, Durand M, van den Blink J W, Gustausson A, McVie J G, et al. The prognosis of Hodgkin's disease in older adults. J Clin Oncol 1991; 9: 947–953
   PubMed Web of Science ®Google Scholar
• Enblad G, Glimelius B, Sundström C. Treatment outcome in Hodgkin's disease in patients above the age of 60: a population-based study. Ann Oncol 1991; 4: 297–302
   Google Scholar
• Erdkamp F L, Breed W P, Bosch L J, Wijnen J T, Blijham G B. Hodgkin's disease in the elderly. A registry-based analysis. Cancer 1992; 70: 830–834
   PubMed Web of Science ®Google Scholar
• Levis A, Depaoli L, Bertini M, Botto B, Ciravegna G, Freilone R, et al. Results of a low aggressivity chemotherapy regimen (CVP/CEB) in elderly Hodgkin's disease patients. Haematologica 1996; 81: 450–456
   PubMed Web of Science ®Google Scholar
• Levis A, Anselmo A P, Ambrosetti A, Adamo F, Bertini M, Cavalieri E, et al. VEPEMB in elderly Hodgkin's lymphoma patients. Results from an Intergruppo Italiano Linfomi (IIL) study. Ann Oncol 2004; 15: 123–128
   PubMed Web of Science ®Google Scholar
• Macpherson N, Klasa R J, Gascoyne R, O'Reilly S E, Voss N, Connors J M. Treatment of elderly Hodgkin's lymphoma patients with a novel 5-drug regimen (ODBEP): a phase II study. Leuk Lymphoma 2002; 43: 1395–1402
   PubMed Web of Science ®Google Scholar
• Ballova V, Rüffer J U, Haverkamp H, Pfistner B, Muller-Hermelink H K, Duhmke E, et al. A prospectively randomized trial carried out by the German Hodgkin Study Group (GHSG) for elderly patients with advanced Hodgkin's disease comparing BEACOPP baseline and COPP-ABVD (study HD9elderly). Ann Oncol 2005; 16: 124–131
   PubMed Web of Science ®Google Scholar
• Weekes C D, Vose J M, Lunch J C, Weisenburger D D, Bierman P J, Greiner T, et al. Hodgkin's disease in the elderly: improved treatment outcome with a doxorubicin-containing regimen. J Clin Oncol 2002; 20: 1087–1093
   PubMed Web of Science ®Google Scholar
• Jarrett R F. Risk factors for Hodgkin's lymphoma by EBV status and significance of detection of EBV genomes in serum of patients with EBV-associated Hodgkin's lymphoma. Leuk Lymphoma 2003; 44(Suppl 3)S27–S32
   PubMed Web of Science ®Google Scholar
• CTC Manual CTEP web site, http://ctep.info.nih.gov/CTC3/ctc.htm
   Google Scholar
• Kim H K, Silver B, Li S, Neuberg D, Mauch P. Hodgkin's disease in elderly patients (> or = 60): clinical outcome and treatment strategies. Int J Radiat Oncol Biol Phys 2003; 56: 556–560
   PubMed Web of Science ®Google Scholar